Schuler Marianne, Schaedelin Sabine, Aebi Christoph, Berger Christoph, Crisinel Pierre-Alex, Diana Alessandro, Niederer-Loher Anita, Siegrist Claire-Anne, Vaudaux Bernard, Heininger Ulrich
From the *Division of Pediatric Infectious Diseases and Vaccinology, University of Basel Children's Hospital, Basel, Switzerland; †Clinical Trial Unit, University of Basel Hospital, Basel, Switzerland; ‡Department of Pediatrics, Bern University Hospital, University of Bern, Bern, Switzerland; §Division of Infectious Diseases and Hospital Epidemiology, and Children's Research Center, University Children's Hospital Zürich, Zürich, Switzerland; ¶Unit of Pediatric Infectious Diseases and Vaccinology, Department of Pediatrics, Lausanne University Hospital, Lausanne, Switzerland; ‖Unit of Pediatric Infectious Diseases, HUG, Geneva, Switzerland; **Pediatrics Center, Clinique des Grangettes, Geneva, Switzerland; ††Unit of Pediatric Infectious Diseases, Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland; and ‡‡Center for Vaccinology, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland.
Pediatr Infect Dis J. 2017 Jun;36(6):e167-e174. doi: 10.1097/INF.0000000000001522.
INFOVAC is a network providing information about immunization issues to health professionals. The aim of this study was to assess the attitude of INFOVAC subscribers toward the current Swiss immunization schedule, potential modifications, and current and hypothetical immunization practices regarding their own children.
In March 2015, a Web-based survey was sent to 4260 physicians and pharmacists subscribed to INFOVAC. Participation was anonymous and voluntary. The following information was obtained: (1) current immunization status of own children; (2) which immunizations would currently be accepted for a hypothetical own child and (3) attitudes toward potential modifications of the Swiss immunization schedule. Descriptive methods and multivariate models to correct for covariables were used for data analysis.
Nine hundred and fifty-five valid questionnaires were received: 886/3704 (23.9%) from physicians and 69/556 (12.4%) from pharmacists. Current (>95%) and hypothetical (>99%) immunization rates were high for diphtheria, tetanus, pertussis, poliomyelitis and measles-mumps-rubella. Most pediatricians (61%) would support more vaccines for their children than currently recommended by the Swiss immunization advisory committee, whereas about 50% of other physicians and pharmacists would decline at least one of the recommended immunizations, most frequently varicella, pneumococcal or meningococcal C conjugate vaccines. Strong general support was expressed for the expansion of human papillomavirus immunization to males, acceleration of the measles-mumps-rubella schedule and a 2 + 1 instead of 3 + 1 diphtheria-tetanus-pertussis, acellular-inactivated poliomyelitis vaccine (DTPa-IPV)/Haemophilus influenzae type b ± hepatitis B virus (HBV) schedule.
Survey participants generally demonstrated a positive attitude toward immunization, with pediatricians being the most progressive subgroup with the largest percentage of participants (63.1%) neither declining nor postponing any recommended immunization.
INFOVAC是一个向卫生专业人员提供免疫接种问题信息的网络。本研究的目的是评估INFOVAC订阅者对当前瑞士免疫接种计划、潜在修改以及他们自己孩子当前和假设的免疫接种做法的态度。
2015年3月，向4260名订阅INFOVAC的医生和药剂师发送了一项基于网络的调查。参与是匿名和自愿的。获得了以下信息：（1）自己孩子当前的免疫接种状况；（2）对于假设的自己的孩子目前会接受哪些免疫接种；（3）对瑞士免疫接种计划潜在修改的态度。使用描述性方法和校正协变量的多变量模型进行数据分析。
共收到955份有效问卷：医生886/3704（23.9%），药剂师69/556（12.4%）。白喉、破伤风、百日咳、脊髓灰质炎和麻疹-腮腺炎-风疹的当前（>95%）和假设（>99%）免疫接种率很高。大多数儿科医生（61%）会支持为他们的孩子接种比瑞士免疫咨询委员会目前建议更多的疫苗，而约50%的其他医生和药剂师至少会拒绝一种推荐的免疫接种，最常见的是水痘、肺炎球菌或C群脑膜炎球菌结合疫苗。对于将人乳头瘤病毒免疫接种扩展到男性、加快麻疹-腮腺炎-风疹计划以及采用2+1而不是3+1的白喉-破伤风-百日咳、无细胞-灭活脊髓灰质炎疫苗（DTPa-IPV）/b型流感嗜血杆菌±乙型肝炎病毒（HBV）计划，普遍表示强烈支持。
调查参与者总体上对免疫接种表现出积极态度，儿科医生是最积极的亚组，最大比例的参与者（63.1%）既不拒绝也不推迟任何推荐的免疫接种。
